Inhaled Immunotherapy for Acute Respiratory Infections
October 7, 2021
Inhalon Doses First Patient in Phase 1 Study of Inhaled IN‑006 to Treat COVID-19 Read more
July 22, 2021
Inhalon Collaborates with Celltrion, Inc. to Develop Nebulized Form of Regdanvimab to Treat COVID-19 Patients at Home Read more
July 16, 2021
Inhalon Biopharma Appoints Jeff Hutchins, Ph.D. as Chief Development Officer Read more
Cruz-Teran C, Tiruthani K, McSweeney M, Ma A, Pickles R Lai SK, Advanced Drug Delivery Reviews, Feb 2021.